In vitro hepatotoxicity evaluation of methotrexate-loaded niosome formulation: fabrication, characterization and cell culture studies
Turkish Journal of Medical Sciences · 18.08.2023 · 53 (4) · 872-882
DOI: 10.55730/1300-0144.5651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 18.08.2023. Verfasst von Ahmet Doğan Ergin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Torino, Torino, Italy; Department of Pharmaceutical Technology, Faculty of Pharmacy, Trakya University, Edi…. Hauptthemen laut MEDLINE: Liposomes, Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/aim: Methotrexate (MTX) is a folic acid antagonist that is widely used to treat osteosarcoma, leukemia, breast cancer, and autoimmune and inflammatory diseases. The most important concerns with MTX are its poor solubility and high toxicity, particularly in liver cells. To enhance its solubility and to minimize its toxicity, we encapsulated MTX in niosomes and investigated its hepatotoxicity mechanisms using genetic biomarkers. Materials and methods: Niosomes were successfully prepared using a modified thin film method, and the prepared monodisperse smallsized formulation was subsequently characterized. In vitro cytotoxicity studies were performed both in hepatocarcinoma (HEP3G) and healthy liver (AML12) cell lines. Specifically, immunofluorescence assay and evaluation of the expression levels of apoptotic, antioxidant, heat shock protein, and oxidative stress genes were performed.
Results
The formulation had a particle size of 117.1 ± 33 nm, a surface charge of -38.41 ± 0.7 mV, and an encapsulation efficiency of 59.7% ± 2.3%. The results showed that the niosomal formulation exhibited significantly higher cytotoxic effects in HEP3G than in AML12. The immunofluorescence and genetic analyses showed that the increased cytotoxicity of niosomes resulted mainly from oxidative stress and slight apoptosis.
Conclusion
These results demonstrated that niosomal drug delivery systems could be a new potential formulation for minimizing MTX-related hepatotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, University of Torino, Torino, Italy; Department of Pharmaceutical Technology, Faculty of Pharmacy, Trakya University, Edirne, Turkiye.
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Trakya University, Edirne, Turkiye.
- Technology Research Development Application and Research Center, Trakya University, Edirne, Turkiye.
- Department of Pharmaceutical Technology, Faculty of Pharmacy, Acıbadem Mehmet Ali Aydınlar University, İstanbul, Turkiye.
Zitieren
APA
Ergin, A. D., Oltulu, Ç., Türker, N. P., & Demirbolat, G. M. (2023). In vitro hepatotoxicity evaluation of methotrexate-loaded niosome formulation: fabrication, characterization and cell culture studies. Turkish Journal of Medical Sciences, 53(4), 872-882. https://doi.org/10.55730/1300-0144.5651
Vancouver
Ergin AD, Oltulu Ç, Türker NP, Demirbolat GM. In vitro hepatotoxicity evaluation of methotrexate-loaded niosome formulation: fabrication, characterization and cell culture studies. Turkish Journal of Medical Sciences. 2023;53(4):872-882. doi:10.55730/1300-0144.5651
BibTeX
@article{Ergin2023,
author = {Ergin, Ahmet Doğan and Oltulu, Çağatay and Türker, Nebiye Pelin and Demirbolat, Gülen Melike},
title = {In vitro hepatotoxicity evaluation of methotrexate-loaded niosome formulation: fabrication, characterization and cell culture studies},
journal = {Turkish Journal of Medical Sciences},
year = {2023},
volume = {53},
number = {4},
pages = {872--882},
doi = {10.55730/1300-0144.5651}
}
EUVIMED